<DOC>
	<DOC>NCT01137786</DOC>
	<brief_summary>This is a pilot study, randomized, double-blind, parallel group comparison of two iodinated contrast agents used during percutaneous coronary intervention (PCI). All patients enrolled must have normal eGFR. Statistical summaries will be presented to analyse the various laboratory tests for the two groups.</brief_summary>
	<brief_title>Kidney Damage in Patients With Normal eGFR</brief_title>
	<detailed_description />
	<mesh_term>Coronary Stenosis</mesh_term>
	<criteria>Provides written Informed Consent and is willing to comply with protocol requirements; Is at least 18 years of age; Is scheduled to undergo a percutaneous coronary intervention and/or diagnostic coronary angiography. Has documented estimated glomerular filtration rate [eGFR] â‰¥60 mL/min/1.73 m2 calculated with the MDRD formula within 72 hours prior to enrollment. Is a pregnant or lactating female. Has a history of severe congestive heart failure Has a history of hyperthyroidism Has a history of hypersensitivity to iodinated contrast agents Has unstable renal function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>